Drugs that contain Rivastigmine Tartrate
1. Exelon patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US4948807 | NOVARTIS | Phenyl carbamates |
Aug, 2012
(11 years ago) | |
| US5602176 | NOVARTIS | Phenyl carbamate |
Feb, 2014
(10 years ago) | |
Market Authorisation Date: 21 April, 2000
Treatment: Treatment of alzheimer's dementia
Dosage: CAPSULE;ORAL; SOLUTION;ORAL
How can I launch a generic of EXELON before it's drug patent expiration?
More Information on Dosage
EXELON family patents
